MEDIROM Healthcare Technologies Inc. (MRM) P/E Ratio History
ExpensiveTrading at 6.0x vs 5Y avg 0.9x · 100th percentile · Material premium to history · Data 2023–2023
Loading P/E history...
P/E Ratio Analysis
As of June 28, 2026, MEDIROM Healthcare Technologies Inc. (MRM) trades at a price-to-earnings ratio of 6.0x, with a stock price of $1.00 and trailing twelve-month earnings per share of $-6.56.
The current P/E is 573% above its 5-year average of 0.9x. Over the past five years, MRM's P/E has ranged from a low of 0.9x to a high of 0.9x, placing the current valuation at the 100th percentile of its historical range.
Compared to the Consumer Cyclical sector median P/E of 21.6x, MRM trades at a 72% discount to its sector peers. The sector includes 309 companies with P/E ratios ranging from 0.1x to 184.9x.
The PEG ratio of 0.13 (P/E divided by 20% EPS growth) suggests the stock may be undervalued relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, MRM trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MRM DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
MRM Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
MRM P/E vs Peers
Health, Fitness and Wellness Services peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $4B | 20.1Lowest | - | +31% | |
| $7B | 66.5 | - | -4% | |
| $7B | 76.3 | 2.15Best | -10% | |
| $971M | 32.8 | - | +104%Best | |
| $622M | 268.5 | - | +104% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
MRM Historical P/E Data (2023–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q4 | Dec 31 2023 | $5.72 | $6.39 | 0.9x | +0% |
Average P/E for displayed period: 0.9x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
3+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MRM — Frequently Asked Questions
Quick answers to the most common questions about buying MRM stock.
What is MRM's P/E ratio?
MEDIROM Healthcare Technologies Inc. (MRM) trailing twelve-month P/E ratio is 6.0x, based on TTM diluted EPS of $-6.56. The 5-year average P/E is 0.9x and the historical range spans 0.9x to 0.9x.
Is MRM stock overvalued or undervalued?
MRM trades at 6.0x P/E, above its 5-year average of 0.9x. The 100th percentile ranking within the 0.9x–0.9x historical range indicates a premium to historical valuation.
Is MRM stock expensive?
Yes, MRM is expensive relative to its own history. The current P/E of 6.0x is above the 5-year average of 0.9x. The stock sits at the 100th percentile of its 5-year valuation range.
What is MRM's historical P/E range?
Over the past 5 years, MRM's P/E ratio has ranged from 0.9x to 0.9x, with a median of 0.9x and an average of 0.9x. The current P/E of 6.0x places the stock at the 100th percentile of this range. Full historical data spans 2023–2023.
How does MRM's P/E compare to the S&P 500?
MRM trades at 6.0x P/E versus the S&P 500 median of 25.3x. The 76% discount to the market suggests lower growth expectations or perceived higher risk.
How does MRM's valuation compare to Consumer Cyclical peers?
MEDIROM Healthcare Technologies Inc. P/E of 6.0x compares to the Consumer Cyclical sector median of 21.6x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is MRM's PEG ratio?
MRM PEG ratio is 0.13, based on a P/E of 6.0x and EPS growth of 20.1%. A PEG below 1.0 indicates the valuation is supported by the earnings growth rate — typically considered attractive.
What is MRM's earnings yield?
MRM earnings yield is 16.59%, the inverse of its 6.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.